| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
fast_grants [2023/05/21 08:38]
liam | fast_grants [2025/07/24 00:06] (current)
liam |
|---|
| | [[Wataru Akahata]] | [[Kyoto University]] | For the development of a Covid-19 vaccine specificially targeted to the receptor-binding domain of the viral S protein using expertise gained during successful development of anti-[[malaria]] and anti-[[chikungunya]] vaccines. | | | [[Wataru Akahata]] | [[Kyoto University]] | For the development of a Covid-19 vaccine specificially targeted to the receptor-binding domain of the viral S protein using expertise gained during successful development of anti-[[malaria]] and anti-[[chikungunya]] vaccines. | |
| | [[James Antaki]] | [[Cornell University]] | For the collaborative effort with [[medical_technology_companies:Accel Diagnostics]] to develop a point of care serological test for rapid quantification of antibody titer to monitor disease progression and strength of immune response. | | | [[James Antaki]] | [[Cornell University]] | For the collaborative effort with [[medical_technology_companies:Accel Diagnostics]] to develop a point of care serological test for rapid quantification of antibody titer to monitor disease progression and strength of immune response. | |
| | [[Susan Athey]] | [[Stanford University]] | | | [[Susan Athey]] | [[Stanford University]] | For retrospective analyses designed to assess the benefit of off-label drug use, in order to help prioritize and guide subsequent randomized clinical trials. | |
| | [[Michael Barry]] | [[Mayo Clinic]] | | | [[Michael Barry]] | [[Mayo Clinic]] | For the development of a single-cycle adenovirus vaccine and viral decoy against SARS-CoV-2. | |
| | [[Mark Bathe]] | [[Massachusetts Institute of Technology]] (MIT) | | | [[Mark Bathe]] | [[Massachusetts Institute of Technology]] (MIT) | For a collaborative effort with the Lingwood and Schmidt labs combining vaccine immunology and nanotechnology expertise to rapidly test and characterize COVID-19 vaccine candidates in high-throughput. | |
| | [[John Bell]] | [[Ottawa Hospital Research Institute]] (OHRI) | | | [[John Bell]] | [[Ottawa Hospital Research Institute]] (OHRI) | To create multiple vaccines for COVID-19 using novel strategies for delivering coronavirus proteins directly to the critical cells required to generate an effective immune response. | |
| | [[Carolyn Bertozzi]] | [[Stanford University]] | | | [[Carolyn Bertozzi]] | [[Stanford University]] | For a collaboration of Dr. Carolyn Bertozzi, Dr. Catherine Blish and Dr. [[Marie Hollenhorst]] to identify minimally invasive predictive biomarkers for Covid-19 disease progression to improve scarce resource allocation. | |
| | [[Lbachir BenMohamed]] | [[University of California Irvine]] | | | [[Lbachir BenMohamed]] | [[University of California Irvine]] | For the development of an asymptomatic multi-epitope COVID-19 vaccine. | |
| | [[Catherine Blish]] | [[Stanford University]] | | | [[Catherine Blish]] | [[Stanford University]] | To determine best practices for N95 mask decontamination that will sufficiently inactivate virus and allow mask reuse in a clinical setting | |
| | [[Jeff Biernaskie]] | [[University of Calgary]] | | | [[Jeff Biernaskie]] | [[University of Calgary]] | To study the immune basis of COVID-19 related [[acute respiratory distress syndrome]] (ARDs) via longitudinal study of patients undergoing placebo and convalescent plasma treatment in order to inform evidence-based repurposing of targeted immunotherapies to improve outcomes for critically-ill patients affected by COVID-19. | |
| | [[Pamela Bjorkman]] | [[California Institute of Technology]] | | | [[Pamela Bjorkman]] | [[California Institute of Technology]] | For electron tomography imaging of SARS-CoV-2 virions trapped in the act of fusion by novel fusion inhibitors | |
| | [[Jim Boonyaratanakornkit]] | [[Fred Hutchinson Cancer Research Center]] | | | [[Jim Boonyaratanakornkit]] | [[Fred Hutchinson Cancer Research Center]] | To probe the human B cell repertoire for SARS-CoV-2-protective B cells from pre-immune individuals in order to guide vaccine and monoclonal antibody design against COVID-19. | |
| | [[Gillian Booth]] | [[University of Toronto]] | | | [[Gillian Booth]] | [[University of Toronto]] | To accelerate the CONNECT study (COVID-19 and diabetes: Clinical Outcomes and Navigated NEtwork Care Today) to define the relationship between diabetes and adverse COVID-19 outcomes and improve care for individuals with diabetes. | |
| | [[Stephen Brohawn]] | [[University of California Berkeley]] | | | [[Stephen Brohawn]] | [[University of California Berkeley]] | To develop novel COVID-19 therapeutics that target coronavirus ion channels in collaboration with the Bautista and Adesnik labs. | |
| | [[James Brian Byrd]] | [[University of Michigan Medical School]] | | | [[James Brian Byrd]] | [[University of Michigan Medical School]] | To support a randomized, controlled clinical trial testing whether continuation, or discontinuation of two common types of blood pressure medication leads to better outcomes in patients hospitalized with COVID-19. | |
| | [[Ann Chahroudi]] | [[Emory University School of Medicine]] | | | [[Ann Chahroudi]] | [[Emory University School of Medicine]] | To investigate cross-reactive, cross-neutralizing, and antibody-dependent enhancing (ADE) antibodies of circulating endemic coronaviruses. | |
| | [[Amy Chung]] | [[University of Melbourne]] | | | [[Amy Chung]] | [[University of Melbourne]] | |
| | [[Susan Daniel]] | [[Cornell University]] | | | [[Susan Daniel]] | [[Cornell University]] | |
| | [[Taia Wang]] | [[Stanford University]] | | | [[Taia Wang]] | [[Stanford University]] | |
| | [[Tania Watts]] | [[University of Toronto]] | | | [[Tania Watts]] | [[University of Toronto]] | |
| | [[Kipp Weiskopf]] | [[Whitehead Institute for Biomedical Research]] | | | [[Kipp Weiskopf]] | [[Whitehead Institute]] | |
| | [[Craig Wilen]] | [[Yale University]] | | | [[Craig Wilen]] | [[Yale University]] | |
| | [[Paul Yager]] | [[University of Washington]] | | | [[Paul Yager]] | [[University of Washington]] | |
| | [[Michael Yin]] | [[Columbia University]] | | | [[Michael Yin]] | [[Columbia University]] | |
| | [[Qian Zhang]] | [[Rockefeller University]] | | | [[Qian Zhang]] | [[Rockefeller University]] | |
| | |
| ===== External links ===== | ===== External links ===== |
| |
| * [[https://fastgrants.org/|Website]] | * [[https://fastgrants.org/|Website]] |
| | * [[https://www.whiteroseintelligence.com/fast-grants/|White Rose Wiki]] |
| * [[https://en.wikipedia.org/wiki/Fast_Grants|Wikipedia]] | * [[https://en.wikipedia.org/wiki/Fast_Grants|Wikipedia]] |
